123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Business >> View Article

Adlib + Generis Conglomerate: A “game Changer” For Regulated Companies

Profile Picture
By Author: InsightsPR
Total Articles: 11
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

New Software Connector Increases Automation and Compliant Management of Document Repositories

Life Science Newswire, London, August 2023 –

An industry-leading software connector has been launched by Adlib Software, a prominent company in document transformation and workflow automation solutions, and Generis, creator of the CARA Platform for data, content, and business process management.

“Adlib’s collaboration with Generis is a significant victory for life science organizations,” according to Helen Rosen, Adlib’s chief executive officer. Through this interface, Adlib’s document rendering technology is accessible to CARA users within the CARA process, allowing clinical and regulatory associates to create submissions more quickly and accurately.

CARA is a platform for managing data and information that aids businesses in regulated sectors, including manufacturing, banking, and energy in streamlining their intricate business operations. The layer built on top is the pre-configured, out-of-the-box CARA Life Sciences PlatformTM®. The platform offers standardized applications for Regulatory, ...
... Quality, Safety, and Clinical processes supported by a single structured data lake that allows robust process optimization and provides users with rapid access to cross-functional data.

Adlib is a native system connector for the CARA Platform that uses the REST API to enable frictionless data transfer between the two systems. Adlib automatically imports all files from the CARA document library when the connection is made, together with the standard and CARA-specific metadata characteristics. After that, Adlib carries out the changes defined in its rule engines, such as OCR, custom header/footer formatting, dynamic table of contents addition, watermarking, and more.

Each document is then converted into a format that is machine-readable and consistent with regulations before being moved to a particular folder in the CARA library. Users may save spending hours managing document repositories manually thanks to this procedure.

James Kelleher, CEO of Generis, said, “We’re thrilled to solidify our connection with Adlib through this connector. With the introduction of this connection, our clients will have access to a coordinated, accurate and dependable engine that controls data, lowers submission mistakes and speeds up the completion of business objectives. For more information about Adlib solutions, email info@adlibsoftware.com. For more information about the CARA Platform, email info@generiscorp.com.

About Adlib

Adlib Software, a Diversis Capital Company and a leading document transformation and workflow automation solution provider, now aims to help organizations scale document workflows, expedite go-to-market activities, and enhance archival and compliance submissions. Adlib Software fully automates the discovery, extraction and conversion of information from an adequate number of document types and formats and creates a shareable and searchable version.

The leading-edge establishments in life sciences, energy, finance and industrials trust Adlib for pixel-perfect rendering. Adlib is a prominent player and a leading establishment in RIM, QMS, ECM and IT solutions and services across regulated industries, including life sciences, energy, manufacturing, insurance, fiscal services, as well as government. To learn more, visit www.adlibsoftware.com.

About Generis

Generis is a UK-based organization leading world-class data, content and business process management for diverse industries on a global scale. 60% of the top 20 life science organizations rely on Generis’ benchmark service – CARA™ Life Sciences Platform, including AbbVie, UCB, Biogen, Reckitt, Bristol Myers Squibb, Bayer, Pfizer and Merck KGaA.

Today, Generis caters to more than 750,000 users worldwide across use cases ranging from RIM, Regulatory/R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information/Medical Affairs applications and more. More at generiscorp.com.

Read More: https://theinsightspr.com/adlib-generis-conglomerate-a-game-changer-for-regulated-companies/

#TopPRagency #publicrelationsserviceproviders #TheInsightsPR #GlobalPRFirmTop #InternationalPRAgency #InternationalPRFirms #BestPRAgency #PublicRelationBlogs

Total Views: 25Word Count: 550See All articles From Author

Add Comment

Business Articles

1. Lucintel Forecasts The Global Agoraphobia Market To Reach $2 Billion By 2030
Author: Lucintel LLC

2. Lucintel Forecasts The Global Acute Care Hospital Bed And Stretcher Market To Reach $11 Billion By 2030
Author: Lucintel LLC

3. Lucintel Forecasts The Global Fibromuscular Dysplasia Treatment Market Is Expected To Grow With A Cagr Of 7.3% From 2024 To 2030
Author: Lucintel LLC

4. Elegant Glass Block Styles To Elevate Your Interior Decor
Author: ADVAN

5. Discover The Beauty Of Floating Stair Treads In Design
Author: ADVAN

6. Maximizing Bulk Sms Services Online
Author: Make My SMS

7. A Comparative Guide For Front-end Development: Angularjs Vs Reactjs
Author: Alena Mage

8. 7 Ways To Find New Donors: Tips For New Nonprofits
Author: Yash

9. Convenient And Reliable Taxi Service In Denver: Serving Thornton And Longmont
Author: Rebecca Jones

10. Sustainability Meets Tech - Eco-friendly Solutions In Modern Interior Design
Author: Alaikha

11. A Brief Guide To Stainless Steel Round Bars
Author: Neelkamal Alloys LLP

12. Digital Marketing And Freelancing: The Perfect Match For The Modern Workforce
Author: shahla

13. Upgrade Your Financial Infrastructure: The Key Role Of An Accounting Data Migration Agency
Author: admin

14. Union Tee Manufacturers In India
Author: Vivek Shah

15. How To Remove Black Magic From Your Home
Author: Shardanand Shastri

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: